Skip to content

Wound healing pattern of PRF and PRGF versus a collagen-based substitute and spontaneous healing– a randomized controlled clinical trial assessing wound closure of an experimental, standardized palatal defect

Wound healing pattern of PRF and PRGF versus a collagen-based substitute and spontaneous healing– a randomized controlled clinical trial assessing wound closure of an experimental, standardized palatal defect

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00034761
Enrollment
20
Registered
2024-09-04
Start date
2024-10-22
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The healing process of palatal wounds

Interventions

Group 1: Four 6mm mucosal samples are taken from the palate and then treated with the different wound dressings. Each of the wounds is then randomly treated with one of the four wound dressing protoco

Sponsors

University of Zürich Center of Dental Medicine Clinic of Reconstructive Dentistry
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Systemically healthy Good oral hygiene (Plaque index <30%) Absence of periodontal disease (Probing depth exceeding 3mm, except third molars) Sufficient space between the first molar and the canine for two 6mm biopsies with at least 3mm in between Sufficiently restored dentition Informed Consent as documented by signature

Exclusion criteria

Exclusion criteria: Previous surgeries at the palate within the last 3 months Uncontrolled diabetes Known coagulation disorders Blood coagulation-altering drugs Smoking of more than 10 cigarettes per day Self-declared pregnancy or breast feeding at the date of inclusion or intending to become pregnant during the course of the study Allergies against local anesthetics Allergies against collagen-based materials Concerns in terms of drawing blood or application of PRF/ PRGF membranes Known or suspected non-compliance, drug or alcohol abuse Inability to follow the procedures of the study, e.g., due to language problems, psychological disorders, dementia, etc. of the participant Participation in another study with investigational drug within the 30 days preceding and during the present study Previous enrolment into the current study Enrolment of the investigator, his/her family members, employees and other dependent persons.

Design outcomes

Primary

MeasureTime frame
The evaluation of wound closure up to 14 days post-surgery. Patients come a total of eight times for a study visit. The first appointment (visit 1) involves the examination for participation in the study and photo documentation. At the second appointment (visit 2), the study intervention takes place, during which four mucosal samples are taken from the palate. The wound treatment of the four sites is randomized. The remaining appointments (visits 3-8) serve to document the healing process of the four mucosal wounds and take place on the 2nd, 5th, 7th, 9th, 12th and 14th day after the study intervention. During the second visit, the actual study intervention takes place and the following is carried out: - Venous blood sampling to prepare the wound dressings from autologous blood - Four circular palatal mucosal aspirates with a diameter of 6 mm - Wound dressings of the 4 resulting wounds + photo documentation At the remaining follow-up visits (visits 3-8), photos are taken to document wound healing. In addition, the patients fill out a questionnaire about their experiences/complaints during the treatment. The study will be completed within 14 days after the treatment.

Secondary

MeasureTime frame
Pain perception over time assessed using an 11-point (i.e. 0-10) numerical rating scale (NRS) (0=no pain; 10=extremely painful) Painkiller consumption: Number of tablets taken after intervention.

Countries

Switzerland

Contacts

Public ContactStefan Bienz

Center of Dental Medicine Clinic of Reconstructive Dentistry University of Zurich

stefan.bienz@zzm.uzh.ch+41 787380308

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026